SHUIMU BIOSCIENCES
Shuimu harnesses the power of cryo-EM and Artificial Intelligence to help pharma and biotech companies discover and develop novel therapeutics faster and better, breaks new ground to develop precision medicines for the most challenging diseases on our planet. With eight 300kv Cryo-EM’s in house, proprietory GraFuture technologies, AI driven data processing and modeling platforms, Shuimu is your best partner with one-stop solutions in structure based drug and therapeutic innovation, from sequence to structure.
SHUIMU BIOSCIENCES
Industry:
Biotechnology Life Science
Founded:
2017-12-07
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.shuimubio.com
Total Employee:
51+
Status:
Active
Contact:
650-680-9298
Email Addresses:
[email protected]
Total Funding:
60 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Apache Mobile Non Scaleable Content COVID-19 Apache 2.4 Ubuntu
Similar Organizations
Current Employees Featured
Founder
Investors List
BOHE Angel Fund
BOHE Angel Fund investment in Angel Round - Shuimu BioSciences
Gaorong Capital
Gaorong Capital investment in Angel Round - Shuimu BioSciences
Puhua Capital
Puhua Capital investment in Angel Round - Shuimu BioSciences
Official Site Inspections
http://www.shuimubio.com
- Host name: ec2-52-9-56-19.us-west-1.compute.amazonaws.com
- IP address: 52.9.56.19
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "Shuimu BioSciences"
Cryo-EM Services for Drug Discovery & Structural …
Shuimu Bio offers 8 available Cryo-EM Krios G4 for CRO services globally: drug discovery, structural biology, supplies and equipment. High-resolution structure analysis, speeding drug research.See details»
Cryo-EM and AI for Next-Gen Drug Discovery.
ShuimuBio hosts high-end 300kV cryo-electron microscopes and delivers high-resolution Single Particle Analysis services acquiring structural information of difficult-to-crystallize biological targets such as transmembrane proteins and …See details»
Shuimu BioSciences - Crunchbase Company Profile
Contact Email [email protected] Phone Number 650-680-9298 Shuimu harnesses the power of cryo-EM and Artificial Intelligence to help pharma and …See details»
Shuimu BioSciences - LinkedIn
Shuimu is a rapidly evolving global cryo-EM & AI platform for early drug discovery, founded in 2017 and headquartered in Beijing, China. Shuimu drives innovation to accelerate the …See details»
Membership - best offer in the industry | Shuimu …
Greetings from Shuimu Biosciences As a member, you not only gain privileged access to our cutting-edge cryo-EM and AI-driven drug discovery services but also become an integral part of a distinguished community committed to …See details»
Advanced Cryo-EM Infrastructure | Shuimu Biosciences
Unlocking the Potential of Cryo-Electron Microscopy Welcome to Shuimu, the leading Asia-Pacific commercial cryo-EM drug discovery platform. Positioned at the vanguard of innovation, we proudly showcase 8 of the latest 300kV cryo …See details»
Shuimu BioSciences - 水木未来（北京）科技有限公司
Speed up everything with ShuimuBio Powered CryoEM Computing Platform. As cryoEM quickly becomes the most preferred technology for structural characterization and candidate …See details»
Shuimu BioSciences - PitchBook
Shuimu BioSciences General Information Description. Provider of comprehensive technical services for pharmaceutical companies. The company provides pharmaceutical companies and drug development companies with Cryo-EM …See details»
Shuimu BioSciences | Cryo-EM and AI for Next-Gen Drug Discovery.
ShuimuBio hosts high-end 300kV cryo-electron microscopes and delivers high-resolution Single Particle Analysis services acquiring structural information of difficult-to-crystallize biological …See details»
Shuimu BioSciences - LinkedIn
Shuimu BioSciences | 794 followers on LinkedIn. Cryo-EM & AI Powered Drug Discovery Powerhouse. | Shuimu is a rapidly evolving global cryo-EM & AI platform for early drug …See details»
CAREER - Shuimu BioSciences - 水木未来（北京）科技有限公司
水木未来(北京)科技有限公司是一家AI+冷冻电镜驱动的新型药物研发平台型公司，建立了亚太第一个300kV冷冻电镜商业化服务平台，基于结构生物学、深度学习和高性能计算核心技术，在小 …See details»
Media & News | Shuimu Biosciences
Cell Cover | Shuimubio Aids in Deciphering Chloroplast Gene Transcription Machinery Read More 2024-03-01 In Silico Discovery of Small Molecule Modulators Targeting the Achilles' Heel of …See details»
Shuimu Biosciences, Biocytogen and others collaborate to publish …
ShuimuBio hosts high-end 300kV cryo-electron microscopes and delivers high-resolution Single Particle Analysis services acquiring structural information of difficult-to-crystallize biological …See details»
Federal government announces support for cutting-edge, AI- and …
4 days ago OmniaBio Inc. is a technology-focused, global cell and gene therapy contract development and manufacturing organization. A subsidiary of the Centre for …See details»
TECHNOLOGY - Shuimu BioSciences | Cryo-EM and AI for Next …
ShuimuBio hosts high-end 300kV cryo-electron microscopes and delivers high-resolution Single Particle Analysis services acquiring structural information of difficult-to-crystallize biological …See details»
China Biologic Products - Wikipedia
The company is engaged in research, manufacturing, and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China.Plasma-based …See details»
Expert Protein Production & Purification | Shuimu Biosciences
Protein Production Shuimu primarily employs three expression systems (bacteria, insect, and mammalian cells) to prepare high-quality target proteins, focusing on challenging proteins like …See details»
Mustang Bio - Wikipedia
Mustang Bio was founded in 2015 and in the same year became a partner company of Fortress Biotech. [5] [7] In April 2017, Manuel Litchman took over as CEO of Mustang Bio, and in …See details»
Scientific Papers: Our Research Publications on CryoEM - Shuimu Bio
Structural insights into the assembly and mechanism of mpox virus DNA polymerase complex F8-A22-E4-H5 November 22, 2023See details»